TELETRADER News
9/9/2020, 8:34 AM (Source: TeleTrader)
more TeleTrader news

AstraZeneca's trial delay isn't big setback - Hancock

The trial of AstraZeneca and Oxford University's COVID-19 vaccine has been paused before, United Kingdom Health Secretary Matt Hancock (pictured) asserted on Wednesday.

Speaking in an interview for Sky News, Hancock asserted that the delay in the study doesn't necessarily represent a significant setback, and stressed that UK government is taking all the steps to ensure that the vaccine is safe.

Earlier today, AstraZeneca has unveiled it will halt the study of its COVID-19 vaccine due to a suspected severe adverse reaction in one participant.

Breaking the News / BU